Copy to clipboard 
I have seen the birth — and near-demise — of many specialties and procedures in the ASC setting over the decades, but nothing compares to the advent and ascent of orthopedic surgery. Orthopedic surgery has emerged as one of the most economically influential forces in outpatient surgery and modern U.S. healthcare. It has already reshaped how musculoskeletal care is delivered, reimbursed and scaled across sites of service.
What initially appeared to be the migration of lower-acuity arthroscopy cases has, over time, evolved into a broader transformation of the orthopedic ecosystem within ASCs. Orthopedics is widely reported to account for a substantial share of ASC surgical volume nationally and is frequently cited as one of the largest contributors to outpatient procedural revenue. This, I can personally attest to as CEO of a surgical group with more than a dozen outpatient locations.
I remember the time when performing ortho and spine in an ASC was considered near-malpractice and placed at the same level of risk-taking as a “Mission: Impossible” stunt. Today, industry observers project that orthopedics’ share of ASC volume will continue to expand through 2030, driven by payor pressure, employer cost-containment strategies, and policy initiatives aimed at shifting procedures away from higher-cost inpatient hospital settings. ASCs have also become central to most orthopedic companies’ strategies as they respond to growing surgeon demand to move procedures to outpatient settings.
The most consequential shift has been the migration of total joint replacements to ASCs. When CPT 27447 (total knee arthroplasty) was removed from the CMS inpatient-only list, it was described as a pivotal inflection point for scale.
Historically, inpatient total knee episode-of-care costs were reported in the $45,000 to $60,000 range, mainly attributable to multi-day admissions, elevated staffing requirements, and downstream post-acute care utilization. Hospital outpatient settings have been reported to reduce these costs to approximately $30,000 to $35,000. However, the lowest episode-of-care expenditures are consistently reported in well-run ASCs, often at a fraction of those figures. High-performing orthopedic ASCs, including our centers in the Midwest, frequently cite bundled episode-of-care ranges between $18,000 and $20,000, and our complication and infection rates are comparable to inpatient benchmarks when appropriate patient selection criteria are applied.
Similarly, commercial total hip replacement facility reimbursements are often reported in the $15,000 to $20,000 range, with commonly cited savings of approximately 30% to 40% compared with hospital-based settings, depending on market and contract structure.
Sports medicine continues to be described as the operational backbone of orthopedic outpatient procedures, providing predictable case volume, rapid room turnover, and favorable margins. These arthroscopic procedures are widely viewed as well-suited to the ASC environment due to short operative times, minimal blood loss, and streamlined closure and postoperative care requirements.
Looking more closely at outpatient surgery revenues, CPT 29827 (arthroscopic rotator cuff repair) is frequently cited as one of the higher-revenue outpatient shoulder procedures, with reported commercial facility reimbursements commonly ranging from $6,500 to $9,500 and professional fees often cited between $1,200 and $1,800, depending on payor mix and geography. The shoulder arthroscopy market is expected to grow in the mid-single digits annually, primarily driven by an aging yet physically active population.
Knee arthroscopy likewise remains a high-volume service line. CPT codes 29881 and 29882 (knee arthroscopy with meniscectomy or meniscal repair, respectively) are often reported to generate approximately $4,000 to $6,000 in ASC facility revenue per case, with many procedures completed in under 45 minutes. CPT 29888 (ACL reconstruction) is generally considered higher acuity and, in favorable contracting environments, is reported to generate facility revenue exceeding $10,000 to $12,000.
Nonsurgical orthopedics is frequently described as an underappreciated economic driver. CPT 20610 (large joint injection or aspiration) is widely cited as one of the most commonly billed orthopedic procedure codes, representing a meaningful proportion of orthopedic encounters. Although per-visit reimbursement is often modest — commonly reported in the $150 to $300 range — nonoperative orthopedics frequently serves as a feeder into higher-value downstream surgical and imaging pathways.
Several orthopedic imaging codes have also been updated in recent years, as reimbursement structures continue to evolve across payor categories. Additionally, upper extremity procedures, from the finger to the elbow, remain an area of meaningful growth.
CPT 64721 (carpal tunnel release) is now routinely performed under local or regional anesthesia, with total room times often under 20 minutes. In my centers, upper extremity cases have similar turnaround and O.R. times to those of endoscopic procedures. Despite its simplicity, ASC facility reimbursement typically ranges from $2,000 to $3,500, making it one of the most profitable procedures on a per-minute basis.
CPT 25447 (thumb CMC arthroplasty) has also shifted decisively to the outpatient environment, frequently generating $6,000 to $8,000 in facility revenue while offering faster recovery and lower infection risk than inpatient alternatives. We routinely do these cases either under local anesthesia or MAC, and the safety profile is superb in the ASC setting.
These simpler surgeries will likely continue migrating to outpatient centers in the near future, with only the most unscrupulous hospitals insisting on performing them in the hospital setting. We saw this scenario play out with ophthalmology in the ’80s, and now it’s orthopedics’ turn. Frankly, it’s about time.
I have seen the birth — and near-demise — of many specialties and procedures in the ASC setting over the decades, but nothing compares to the advent and ascent of orthopedic surgery. Orthopedic surgery has emerged as one of the most economically influential forces in outpatient surgery and modern U.S. healthcare. It has already reshaped how...
I have seen the birth — and near-demise — of many specialties and procedures in the ASC setting over the decades, but nothing compares to the advent and ascent of orthopedic surgery. Orthopedic surgery has emerged as one of the most economically influential forces in outpatient surgery and modern U.S. healthcare. It has already reshaped how musculoskeletal care is delivered, reimbursed and scaled across sites of service.
What initially appeared to be the migration of lower-acuity arthroscopy cases has, over time, evolved into a broader transformation of the orthopedic ecosystem within ASCs. Orthopedics is widely reported to account for a substantial share of ASC surgical volume nationally and is frequently cited as one of the largest contributors to outpatient procedural revenue. This, I can personally attest to as CEO of a surgical group with more than a dozen outpatient locations.
I remember the time when performing ortho and spine in an ASC was considered near-malpractice and placed at the same level of risk-taking as a “Mission: Impossible” stunt. Today, industry observers project that orthopedics’ share of ASC volume will continue to expand through 2030, driven by payor pressure, employer cost-containment strategies, and policy initiatives aimed at shifting procedures away from higher-cost inpatient hospital settings. ASCs have also become central to most orthopedic companies’ strategies as they respond to growing surgeon demand to move procedures to outpatient settings.
The most consequential shift has been the migration of total joint replacements to ASCs. When CPT 27447 (total knee arthroplasty) was removed from the CMS inpatient-only list, it was described as a pivotal inflection point for scale.
Historically, inpatient total knee episode-of-care costs were reported in the $45,000 to $60,000 range, mainly attributable to multi-day admissions, elevated staffing requirements, and downstream post-acute care utilization. Hospital outpatient settings have been reported to reduce these costs to approximately $30,000 to $35,000. However, the lowest episode-of-care expenditures are consistently reported in well-run ASCs, often at a fraction of those figures. High-performing orthopedic ASCs, including our centers in the Midwest, frequently cite bundled episode-of-care ranges between $18,000 and $20,000, and our complication and infection rates are comparable to inpatient benchmarks when appropriate patient selection criteria are applied.
Similarly, commercial total hip replacement facility reimbursements are often reported in the $15,000 to $20,000 range, with commonly cited savings of approximately 30% to 40% compared with hospital-based settings, depending on market and contract structure.
Sports medicine continues to be described as the operational backbone of orthopedic outpatient procedures, providing predictable case volume, rapid room turnover, and favorable margins. These arthroscopic procedures are widely viewed as well-suited to the ASC environment due to short operative times, minimal blood loss, and streamlined closure and postoperative care requirements.
Looking more closely at outpatient surgery revenues, CPT 29827 (arthroscopic rotator cuff repair) is frequently cited as one of the higher-revenue outpatient shoulder procedures, with reported commercial facility reimbursements commonly ranging from $6,500 to $9,500 and professional fees often cited between $1,200 and $1,800, depending on payor mix and geography. The shoulder arthroscopy market is expected to grow in the mid-single digits annually, primarily driven by an aging yet physically active population.
Knee arthroscopy likewise remains a high-volume service line. CPT codes 29881 and 29882 (knee arthroscopy with meniscectomy or meniscal repair, respectively) are often reported to generate approximately $4,000 to $6,000 in ASC facility revenue per case, with many procedures completed in under 45 minutes. CPT 29888 (ACL reconstruction) is generally considered higher acuity and, in favorable contracting environments, is reported to generate facility revenue exceeding $10,000 to $12,000.
Nonsurgical orthopedics is frequently described as an underappreciated economic driver. CPT 20610 (large joint injection or aspiration) is widely cited as one of the most commonly billed orthopedic procedure codes, representing a meaningful proportion of orthopedic encounters. Although per-visit reimbursement is often modest — commonly reported in the $150 to $300 range — nonoperative orthopedics frequently serves as a feeder into higher-value downstream surgical and imaging pathways.
Several orthopedic imaging codes have also been updated in recent years, as reimbursement structures continue to evolve across payor categories. Additionally, upper extremity procedures, from the finger to the elbow, remain an area of meaningful growth.
CPT 64721 (carpal tunnel release) is now routinely performed under local or regional anesthesia, with total room times often under 20 minutes. In my centers, upper extremity cases have similar turnaround and O.R. times to those of endoscopic procedures. Despite its simplicity, ASC facility reimbursement typically ranges from $2,000 to $3,500, making it one of the most profitable procedures on a per-minute basis.
CPT 25447 (thumb CMC arthroplasty) has also shifted decisively to the outpatient environment, frequently generating $6,000 to $8,000 in facility revenue while offering faster recovery and lower infection risk than inpatient alternatives. We routinely do these cases either under local anesthesia or MAC, and the safety profile is superb in the ASC setting.
These simpler surgeries will likely continue migrating to outpatient centers in the near future, with only the most unscrupulous hospitals insisting on performing them in the hospital setting. We saw this scenario play out with ophthalmology in the ’80s, and now it’s orthopedics’ turn. Frankly, it’s about time.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
SA
Shakeel Ahmed M.D., is the CEO of Atlas Surgical Group, one of the largest ambulatory surgical centers and ancillary services networks in the Midwest. He has published fifteen books and more than three hundred articles on the business aspects of ASCs. He is an ASC developer and advisor to governments across the globe and serves on advisory boards for surgical center development in multiple Western countries.
